Press releases
- Accuray Expands Global Training Center Network With Opening of New Facility in Genolier, Switzerland
- Accuray to Report Third Quarter Fiscal 2024 Financial Results on May 1, 2024
- New Data from Two Clinical Studies Indicate High-Risk and Recurrent Prostate Cancers Can be Effectively Treated in 5 Days Using the Accuray CyberKnife® System
- Accuray Incorporated to Speak at Oppenheimer 34th Annual Healthcare MedTech & Services Conference
- Quebec Cancer Center is First in Canada to Treat Cancer Patients Using the Accuray Radixact® System
- Accuray to Participate in the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference
- Accuray Reports Fiscal 2024 Second Quarter Financial Results
- Providence Swedish Radiosurgery Center in Seattle Invests in Second Accuray CyberKnife® System, a Robotic Delivery Device That Makes Extremely Precise Radiation Treatments Possible in 1-5 Sessions
More ▼
Key statistics
On Monday, Accuray Inc (0H8I:LSE) closed at 2.14, 0.14% above its 52-week low of 2.14, set on Apr 22, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | -- |
---|---|
High | -- |
Low | -- |
Bid | -- |
Offer | -- |
Previous close | 2.14 |
Average volume | 333.67 |
---|---|
Shares outstanding | 99.17m |
Free float | 95.62m |
P/E (TTM) | -- |
Market cap | 215.20m USD |
EPS (TTM) | -0.1496 USD |
Data delayed at least 20 minutes, as of Apr 22 2024 17:27 BST.
More ▼